Allogene Therapeutics, Inc. - COM (ALLO)

Q4 2019 13F Holders as of 12/31/2019

Type / Class
Equity / COM
Number of holders
115
Total Shares
71.6M
Shares change
+2.87M
Total reported value, excl. options
$1.86B
Value change
+$73.7M
Put/Call ratio
0.92
Number of buys
67
Number of sells
-36
Price
$25.98
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.